Condition: Cirrhosis · Diabetes Mellitus · Oncologic Disorders · Sponsor: Consorcio Centro de Investigación Biomédica en Red (CIBER)
The purpose of this study is to assess the superiority of esmolol echocardiography over conventional echocardiography in the diagnosis of subclinical myocardial involvement associated with diabetes mellitus 2, cirrhosis and antineoplastic treatments.
This description comes directly from the study's public registry record.
Tania Luis García, BS · +34 917996034 · tanialuisgarcia@cibercv.es
Projects Department (CIBER) · +34 918222874 · proyectos@ciberisciii.es
Always discuss trial participation with your own doctor first.
| Hospital Universitari Vall d'Hebron | Barcelona, Barcelona, Spain | Recruiting |
| Hospital Clínic de Barcelona | Barcelona, Barcelona, Spain | Not Yet Recruiting |
| Hospital General Universitario Gregorio Marañón | Madrid, Madrid, Spain | Recruiting |
| Hospital Universitario La Paz | Madrid, Madrid, Spain | Recruiting |
| Hospital Clínico Universitario de Salamanca | Salamanca, Salamanca, Spain | Recruiting |
| Hospital Universitari i Politècnic La Fe | Valencia, Valencia, Spain | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05769868